# The Barbara Ann Karmanos Cancer Institute

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/the-barbara-ann-karmanos-cancer-institute/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 70.7 |
| Citations | 1,413,150 |
| City | Detroit |
| Country | US |
| Description | The Barbara Ann Karmanos Cancer Institute is a research organisation in Detroit, US. OpenAlex records 12,275 works and 1,413,150 citations for it. 1,636 researchers list it as their most recent affiliation. |
| Homepage | https://www.karmanos.org |
| OpenAlex ID | https://openalex.org/I4210090317 |
| Researchers | 1,636 |
| ROR ID | https://ror.org/00ee40h97 |
| Type | facility |
| Works | 12,275 |

## University papers

- [2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline](https://scholariq.org/papers/2006-update-of-recommendations-for-the-use-of-white-blood-cell-growth-factors-an/)
- [Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia](https://scholariq.org/papers/intensive-postremission-chemotherapy-in-adults-with-acute-myeloid-leukemia/)
- [Duration of Adjuvant Chemotherapy for Stage III Colon Cancer](https://scholariq.org/papers/duration-of-adjuvant-chemotherapy-for-stage-iii-colon-cancer/)
- [2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines](https://scholariq.org/papers/2000-update-of-recommendations-for-the-use-of-hematopoietic-colony-stimulating/)
- [Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia](https://scholariq.org/papers/granulocyte-macrophage-colony-stimulating-factor-after-initial-chemotherapy-for/)
- [Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered](https://scholariq.org/papers/patients-with-t-8-21-q22-q22-and-acute-myeloid-leukemia-have-superior-failure/)

## University top topics

Showing 8 of 25.

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.